Comparative study of six-month and eight-month treatment of new smear positive tuberculosis cases at a tertiary health facility in Enugu, South-Eastern Nigeria

Introduction: Factors that affect tuberculosis (TB) treatment outcomes are important and should be investigated to achieve the targets of TB control program. Aims and Objectives: The aim of this study was to compare treatment outcomes of new smear positive TB patients treated for six months with tho...

Full description

Bibliographic Details
Main Authors: Babatunde I Omotowo, Ijeoma Itanyi, Edmund O Ndibuagu, Chuka C Agunwa, Ikechukwu E Obi, Arthur C Idoko, Anne C Ndu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:International Journal of Medicine and Health Development
Subjects:
Online Access:http://www.ijmhdev.com/article.asp?issn=2635-3695;year=2019;volume=24;issue=2;spage=78;epage=84;aulast=Omotowo
_version_ 1811180090287980544
author Babatunde I Omotowo
Ijeoma Itanyi
Edmund O Ndibuagu
Chuka C Agunwa
Ikechukwu E Obi
Arthur C Idoko
Anne C Ndu
author_facet Babatunde I Omotowo
Ijeoma Itanyi
Edmund O Ndibuagu
Chuka C Agunwa
Ikechukwu E Obi
Arthur C Idoko
Anne C Ndu
author_sort Babatunde I Omotowo
collection DOAJ
description Introduction: Factors that affect tuberculosis (TB) treatment outcomes are important and should be investigated to achieve the targets of TB control program. Aims and Objectives: The aim of this study was to compare treatment outcomes of new smear positive TB patients treated for six months with those treated for eight months. Materials and Methods: A retrospective study of 600 new smear-positive TB patients was carried out. The data were analyzed using Stata version 22 (SPSS Inc., Chicago, Illinois, USA), and the values of P < 0.05 were considered statistically significant. Binary logistic regression was used to identify factors that influenced treatment outcomes. Results: Overall, a higher proportion of patients (78.6%) who were treated for six months had successful treatment outcomes as compared with those treated for eight months 64.4% (P = < 0.001, OR = 2.03, CI = 1.41–2.91). After adjusting for confounders, sex (P = 0.040, AOR = 0.65, CI = 0.44–0.98), treatment duration (P < 0.001, AOR = 2.27, CI = 1.53–3.39), and pretreatment weight (P = 0.007, AOR = 1.28, CI = 1.07–1.52) independently predicted treatment outcome. Conclusion: The treatment success rate was better among the patients treated for six-month duration than those treated for eight-month duration. The current six-month regimen recommended by WHO should be maintained. Loss to follow-up and TB/HIV coinfection management should be improved.
first_indexed 2024-04-11T06:45:41Z
format Article
id doaj.art-5234b7589ccf4b5297032920386d4117
institution Directory Open Access Journal
issn 2635-3695
language English
last_indexed 2024-04-11T06:45:41Z
publishDate 2019-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series International Journal of Medicine and Health Development
spelling doaj.art-5234b7589ccf4b5297032920386d41172022-12-22T04:39:22ZengWolters Kluwer Medknow PublicationsInternational Journal of Medicine and Health Development2635-36952019-01-01242788410.4103/ijmh.IJMH_24_19Comparative study of six-month and eight-month treatment of new smear positive tuberculosis cases at a tertiary health facility in Enugu, South-Eastern NigeriaBabatunde I OmotowoIjeoma ItanyiEdmund O NdibuaguChuka C AgunwaIkechukwu E ObiArthur C IdokoAnne C NduIntroduction: Factors that affect tuberculosis (TB) treatment outcomes are important and should be investigated to achieve the targets of TB control program. Aims and Objectives: The aim of this study was to compare treatment outcomes of new smear positive TB patients treated for six months with those treated for eight months. Materials and Methods: A retrospective study of 600 new smear-positive TB patients was carried out. The data were analyzed using Stata version 22 (SPSS Inc., Chicago, Illinois, USA), and the values of P < 0.05 were considered statistically significant. Binary logistic regression was used to identify factors that influenced treatment outcomes. Results: Overall, a higher proportion of patients (78.6%) who were treated for six months had successful treatment outcomes as compared with those treated for eight months 64.4% (P = < 0.001, OR = 2.03, CI = 1.41–2.91). After adjusting for confounders, sex (P = 0.040, AOR = 0.65, CI = 0.44–0.98), treatment duration (P < 0.001, AOR = 2.27, CI = 1.53–3.39), and pretreatment weight (P = 0.007, AOR = 1.28, CI = 1.07–1.52) independently predicted treatment outcome. Conclusion: The treatment success rate was better among the patients treated for six-month duration than those treated for eight-month duration. The current six-month regimen recommended by WHO should be maintained. Loss to follow-up and TB/HIV coinfection management should be improved.http://www.ijmhdev.com/article.asp?issn=2635-3695;year=2019;volume=24;issue=2;spage=78;epage=84;aulast=Omotowoeight monthsnigeriasix monthssmear positivetreatment outcomestuberculosis
spellingShingle Babatunde I Omotowo
Ijeoma Itanyi
Edmund O Ndibuagu
Chuka C Agunwa
Ikechukwu E Obi
Arthur C Idoko
Anne C Ndu
Comparative study of six-month and eight-month treatment of new smear positive tuberculosis cases at a tertiary health facility in Enugu, South-Eastern Nigeria
International Journal of Medicine and Health Development
eight months
nigeria
six months
smear positive
treatment outcomes
tuberculosis
title Comparative study of six-month and eight-month treatment of new smear positive tuberculosis cases at a tertiary health facility in Enugu, South-Eastern Nigeria
title_full Comparative study of six-month and eight-month treatment of new smear positive tuberculosis cases at a tertiary health facility in Enugu, South-Eastern Nigeria
title_fullStr Comparative study of six-month and eight-month treatment of new smear positive tuberculosis cases at a tertiary health facility in Enugu, South-Eastern Nigeria
title_full_unstemmed Comparative study of six-month and eight-month treatment of new smear positive tuberculosis cases at a tertiary health facility in Enugu, South-Eastern Nigeria
title_short Comparative study of six-month and eight-month treatment of new smear positive tuberculosis cases at a tertiary health facility in Enugu, South-Eastern Nigeria
title_sort comparative study of six month and eight month treatment of new smear positive tuberculosis cases at a tertiary health facility in enugu south eastern nigeria
topic eight months
nigeria
six months
smear positive
treatment outcomes
tuberculosis
url http://www.ijmhdev.com/article.asp?issn=2635-3695;year=2019;volume=24;issue=2;spage=78;epage=84;aulast=Omotowo
work_keys_str_mv AT babatundeiomotowo comparativestudyofsixmonthandeightmonthtreatmentofnewsmearpositivetuberculosiscasesatatertiaryhealthfacilityinenugusoutheasternnigeria
AT ijeomaitanyi comparativestudyofsixmonthandeightmonthtreatmentofnewsmearpositivetuberculosiscasesatatertiaryhealthfacilityinenugusoutheasternnigeria
AT edmundondibuagu comparativestudyofsixmonthandeightmonthtreatmentofnewsmearpositivetuberculosiscasesatatertiaryhealthfacilityinenugusoutheasternnigeria
AT chukacagunwa comparativestudyofsixmonthandeightmonthtreatmentofnewsmearpositivetuberculosiscasesatatertiaryhealthfacilityinenugusoutheasternnigeria
AT ikechukwueobi comparativestudyofsixmonthandeightmonthtreatmentofnewsmearpositivetuberculosiscasesatatertiaryhealthfacilityinenugusoutheasternnigeria
AT arthurcidoko comparativestudyofsixmonthandeightmonthtreatmentofnewsmearpositivetuberculosiscasesatatertiaryhealthfacilityinenugusoutheasternnigeria
AT annecndu comparativestudyofsixmonthandeightmonthtreatmentofnewsmearpositivetuberculosiscasesatatertiaryhealthfacilityinenugusoutheasternnigeria